Smoking Cessation Program in the Preadmission Clinic

PHASE4UnknownINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

June 30, 2011

Conditions
Smoking
Interventions
BEHAVIORAL

Smoking counseling

Preoperative and postoperative counseling sessions provided by a trained smoking counselor along with placebo.

DRUG

varenicline

varenicline (an approved medication for smoking cessation)

DRUG

placebo

sugar pill without any active medication

Trial Locations (1)

M5T 2S8

RECRUITING

Toronto Western Hospital, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University Health Network, Toronto

OTHER

NCT00937508 - Smoking Cessation Program in the Preadmission Clinic | Biotech Hunter | Biotech Hunter